Johan Nicolaï

10PUBLICATIONS
27CO-AUTHORS
Molecular targetsPharmacogenomicsNeonatologyPharmaceutical delivery technologiesBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 26, 2025
Discovery of Gut-Restricted PRMT5 Inhibitors to Intercept Colorectal Cancer in Patients with Genetic Loss of Tumor Suppressor Adenomatous Polyposis Coli.

Fabian Hulpia, Wim Schepens, Susan Lepri

|Feb 20, 2021
Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species.

B D van Groen, J Nicolaï, A C Kuik

|Oct 21, 2020
Population pharmacokinetics of propofol in neonates and infants: Gestational and postnatal age to determine clearance maturation.

Louis Sandra, Anne Smits, Karel Allegaert

|Aug 29, 2020
Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio.

Johan Nicolaï, Hélène Chapy, Eric Gillent

|Aug 26, 2020
(-)-N-3-Benzylphenobarbital Is Superior to Omeprazole and (+)-N-3-Benzylnirvanol as a CYP2C19 Inhibitor in Suspended Human Hepatocytes.

Marie-Lynn Cuypers, Hugues Chanteux, Eric Gillent

|Aug 22, 2020
Use of a physiologically based pharmacokinetic-pharmacodynamic model for initial dose prediction and escalation during a paediatric clinical trial.

Trevor N Johnson, Khaled Abduljalil, Jean-Marie Nicolas

Pageof 2

Frequent Collaborators

3 joint publications

Pieter Annaert

1 joint publications

Arianna Giusti

1 joint publications

Xuan-Bac Nguyen

1 joint publications

Peter de Witte